Innovative packaging design aids convergence in the pharmaceutical industry

Sep 30 2013

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing how it’s innovative packaging design aids convergence in the pharmaceutical industry. The white paper is available to download via PCI Convergence White Paper and discusses convergence in a variety of fields within the pharmaceutical industry, as well as identifying the benefits and challenges. The paper goes on to outline how PCI’s services provide innovative solutions to meet these evolving markets.

Recent reports indicate that convergence is playing a large part in the growth of the pharmaceutical market. The need for convergence has become more apparent in recent years due to the declining economy and the increase in competition within the market, thus the need for collaboration between various sectors, allowing organizations to expand into other lucrative areas.

One of the biggest opportunities for pharmaceutical companies is the conversion of prescription drugs (Rx) to over the counter products (OTC). Market growth in this sector is being driven by patent expirations and an increasing number of large pharmaceutical companies looking to expand their consumer health business. PCI anticipated a surge in companies expanding into OTC markets and developed a partnership with a packaging design company to help provide solutions to the challenges associated with competitive consumer markets. One of its latest innovations is their pocket pack, which has already been used by a number of health care organisations.

Convergence comes in numerous forms and applies to several aspects of the pharmaceutical market, including the highly lucrative over the counter, nutraceutical, cosmecutical and veterinary markets. The nutraceutical sector combines a number of prominent markets, including food and beverage and pharmaceuticals thus creating the popular convergence of food-based products with medical and general health benefits. The global nutraceutical market in 2011 was reported to be worth approximately $149.5 billion, with the US, Europe and Japan being the largest regional markets, accounting for nearly 93 percent of the global nutraceutical demand.

As a result of convergence within the pharmaceutical market, competition looks set to escalate and packaging innovation is likely to play a key role in brand owners’ strategies. By adopting strong branding and innovative packaging designs that incorporate compliance and anti-counterfeit measures, the world’s major pharmaceutical companies can begin to win themselves a significant share of these sectors.

For more information on PCI and its services, please email [email protected], call +44 (0) 1497 820829 or visit www.pciservices.com

About Packaging Coordinators, Inc.

Packaging Coordinators, Inc. offers unparalleled expertise in a range of proprietary pharmaceutical and biotechnology packaging innovations for healthcare clients across all markets. PCI leads the field in providing cutting-edge customized healthcare packaging solutions that improve patient adherence and uphold the most stringent safety requirements. For more information about PCI and its state of the art facilities in Philadelphia, PA and Woodstock, IL, visit the company’s website at www.pciservices.com